RELV - RELIV INTERNATIONAL INC

2.25
0   0%

Share volume: 538
Last Updated: 01-21-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$2.25
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-16.67%
6 Months
-25.00%
1 Year
-25.00%
2 Year
-25.00%
Key data
Stock price
$2.25
P/E Ratio 
N/A
DAY RANGE
$1.92 - $2.25
EPS 
N/A
52 WEEK RANGE
$1.70 - $3.00
52 WEEK CHANGE
-$25.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Ryan A. Montgomery
Region: US
Website: reliv.com
Employees: 90
IPO year: 2020
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Reliv' International, Inc. develops and markets nutritional supplements. Products address basic nutrition, specific wellness needs, weight management, and sports nutrition. Products include Reliv Classic, Reliv Now, Innergize! and FibRestore along with LunaRich X capsules.

Recent news